Literature DB >> 523360

In vitro synergy and antagonism of antifungal agents against yeast-like fungi.

B Dupont, E Drouhet.   

Abstract

Some antifungal agents have been tested qualitatively in various associations against species of Candida, Cryptococcus and Torulopsis. The method used was the channel test and the results are confirmed by comparison with the serial dilution test in agar. The antagonism in vitro with the combination of amphotericin B imidazole suggests that caution must be exercised before prescribing the antifungal drugs in combination for man. The frequent synergy of flucytosine with econazole is, however, encouraging because of the low toxicity of the 2 drugs. Under the limited conditions described, the combination of flucytosine and amphotericin B was not found synergistic but additive on the strains of C. albicans used in this study. This combination was found synergistic for a strain of C. parapsilosis and is useful for avoiding resistance to flucytosine.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 523360      PMCID: PMC2425645          DOI: 10.1136/pgmj.55.647.683

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  4 in total

1.  In vitro studies with combinations of 5-fluorocytosine and amphotericin B.

Authors:  S Shadomy; G Wagner; E Espinel-Ingroff; B A Davis
Journal:  Antimicrob Agents Chemother       Date:  1975-08       Impact factor: 5.191

2.  [First medical cure of Candida endocarditis on a valve prosthesis].

Authors:  B Dupont; E Drouhet; C Lapresle
Journal:  Ann Med Interne (Paris)       Date:  1977 Aug-Sep

3.  Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms.

Authors:  G Medoff; M Comfort; G S Kobayashi
Journal:  Proc Soc Exp Biol Med       Date:  1971-11

4.  Letter: Antagonism between miconazole and amphotericin B.

Authors:  L P Schacter; R J Owellen; H K Rathbun; B Buchanan
Journal:  Lancet       Date:  1976-08-07       Impact factor: 79.321

  4 in total
  15 in total

Review 1.  Combination antifungal therapy.

Authors:  Melissa D Johnson; Conan MacDougall; Luis Ostrosky-Zeichner; John R Perfect; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

2.  Multifactorial analysis of effects of interactions among antifungal and antineoplastic drugs on inhibition of Candida albicans growth.

Authors:  M A Ghannoum; M S Motawy; M A Abu Hatab; A S Ibrahim; R S Criddle
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

Review 3.  Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans.

Authors:  Jinhui Cui; Biao Ren; Yaojun Tong; Huanqin Dai; Lixin Zhang
Journal:  Virulence       Date:  2015       Impact factor: 5.882

4.  Assay of fluconazole by megabore capillary gas-liquid chromatography with nitrogen-selective detection.

Authors:  S C Harris; J E Wallace; G Foulds; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

Review 5.  Fungal endocarditis: patients at risk and their treatment.

Authors:  M S Seelig; P J Kozinin; P Goldberg; A R Berger
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

6.  Effect of ketoconazole on the fungicidal action of amphotericin B in Candida albicans.

Authors:  I J Sud; D S Feingold
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

7.  Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.

Authors:  F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

8.  Entry of ketoconazole into Candida albicans.

Authors:  P Boiron; E Drouhet; B Dupont; L Improvisi
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

9.  Problems in antifungal chemotherapy.

Authors:  D A Stevens
Journal:  Infection       Date:  1987 Mar-Apr       Impact factor: 3.553

10.  Combined activity of ketoconazole and 5-fluorocytosine on potentially pathogenic yeasts.

Authors:  W H Beggs; G A Sarosi
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.